https://www.reteoncologicaropi.it/wp-content/uploads/2022/04/Farm_endo.jpg
684
845
https://www.reteoncologicaropi.it/wp-content/uploads/2021/06/ROPI-DEF-1.png
2022-04-04 09:56:022022-04-04 09:56:02CARCINOMA DELL’ENDOMETRIO
https://www.reteoncologicaropi.it/wp-content/uploads/2021/12/SACITUZUMAB_GOVITECAN-1.jpg
684
845
https://www.reteoncologicaropi.it/wp-content/uploads/2021/06/ROPI-DEF-1.png
2021-12-17 14:20:212022-03-10 11:44:22SACITUZUMAB GOVITECAN
https://www.reteoncologicaropi.it/wp-content/uploads/2021/02/PEMIGATINIB-1.jpg
684
845
https://www.reteoncologicaropi.it/wp-content/uploads/2021/06/ROPI-DEF-1.png
2021-02-23 10:36:142022-03-10 11:44:56PEMIGATINIB nel Colangiocarcinoma
https://www.reteoncologicaropi.it/wp-content/uploads/2021/01/AVELUMAB-1.jpg
684
845
https://www.reteoncologicaropi.it/wp-content/uploads/2021/06/ROPI-DEF-1.png
2021-01-25 12:07:562022-03-10 11:46:29AVELUMAB e carcinoma uroteliale
https://www.reteoncologicaropi.it/wp-content/uploads/2021/01/DOSTARLIMAB-1.jpg
684
845
https://www.reteoncologicaropi.it/wp-content/uploads/2021/06/ROPI-DEF-1.png
2021-01-22 13:55:512022-03-10 11:39:31DOSTARLIMAB e carcinoma dell’endometrio
Scorrere verso l’alto